Investors aren't giving management the benefit of the doubt on much of anything at the moment and this is probably deserved.

Will the company take another steep dividend increase? Will the company embark on a more sizeable share buyback program? Will the company make any corporate acquisitions? Pfizer could conceivably do all of the above.

One aspect of the Pfizer story that is more difficult to nail down is how the company will use its sizeable cash hoards.

In one sense, you can be really excited about this because it shows gay and lesbian relationships are getting to be more accepted and [Schneider National] is actively seeking those employees to work for them.

Appears to be a good quarter overall, driven by strong top-line growth and continued improvement in gross margins.

It may be wise to take profits on the news,